Neurology devices are specialized surgical devices used for the treatment of disease or conditions of the central nervous system (CNS) and spine. Neurodiagnostic tests are used to diagnose suspected neurological disorders through electroencephalographs (EEG), electromyographs (EMG), or magnetoencephalography (MEG) by looking at brain activity. GlobalData uses proprietary data and analytics to provide a comprehensive report on the electrical activity testing market in New Zealand. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the electrical activity testing market in New Zealand was Natus Medical followed by Electrical Geodesics, Masimo, Medtronic, Nihon Kohden, OT Bioelettronica and Magstim.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Electroencephalograms are used to diagnose issues related to the electrical activity of the brain. Electromyograms are used to measure muscle activities and nerves in response to electrical activity. Magnetoencephalogram tests are the most advanced method of studying brain activity while actively functioning.
The electrical activity testing market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size electrical activity testing in New Zealand, buy the report here.